These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31521680)
1. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease. Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680 [TBL] [Abstract][Full Text] [Related]
2. Inaccurate diagnosis of COPD: the Welsh National COPD Audit. Fisk M; McMillan V; Brown J; Holzhauer-Barrie J; Khan MS; Baxter N; Roberts CM Br J Gen Pract; 2019 Jan; 69(678):e1-e7. PubMed ID: 30559109 [TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap. Su VY; Yang YH; Perng DW; Tsai YH; Chou KT; Su KC; Su WJ; Chen PC; Yang KY Aging (Albany NY); 2019 Jun; 11(11):3650-3667. PubMed ID: 31175265 [TBL] [Abstract][Full Text] [Related]
4. Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit? Currie GP; Lipworth BJ QJM; 2016 Aug; 109(8):505-12. PubMed ID: 26559079 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Jones RC; Dickson-Spillmann M; Mather MJ; Marks D; Shackell BS Respir Res; 2008 Aug; 9(1):62. PubMed ID: 18710575 [TBL] [Abstract][Full Text] [Related]
6. Implementation of guideline-based therapy for chronic obstructive pulmonary disease: Differences between men and women veterans. Rinne ST; Elwy AR; Liu CF; Wiener RS; Thayer L; Gerity A; Bastian LA Chron Respir Dis; 2017 Nov; 14(4):385-391. PubMed ID: 28618875 [TBL] [Abstract][Full Text] [Related]
7. Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD. Papala M; Kerenidi N; Gourgoulianis KI Prim Care Respir J; 2013 Sep; 22(3):362-4. PubMed ID: 23989678 [No Abstract] [Full Text] [Related]
8. Chronic Obstructive Pulmonary Disease in Heart Failure: Challenges in Diagnosis and Treatment for HFpEF and HFrEF. Ramalho SHR; de Albuquerque ALP Curr Heart Fail Rep; 2024 Jun; 21(3):163-173. PubMed ID: 38546964 [TBL] [Abstract][Full Text] [Related]
9. Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register. Arcoraci V; Squadrito F; Rottura M; Barbieri MA; Pallio G; Irrera N; Nobili A; Natoli G; Argano C; Squadrito G; Corrao S Front Cardiovasc Med; 2022; 9():876693. PubMed ID: 35651906 [TBL] [Abstract][Full Text] [Related]
11. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975 [TBL] [Abstract][Full Text] [Related]
12. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. Du Q; Sun Y; Ding N; Lu L; Chen Y PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000 [TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical treatment status of patients with COPD in the community based on medical Internet of Things: a real-world study. Wu P; Jiang YQ; Si FL; Wang HY; Song XB; Sheng CF; Xu X; Li F; Zhang J NPJ Prim Care Respir Med; 2024 May; 34(1):10. PubMed ID: 38729942 [TBL] [Abstract][Full Text] [Related]
14. Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study. Lin SJ; Liao XM; Chen NY; Chang YC; Cheng CL BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37989489 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care. Hawkins NM; Peterson S; Salimian S; Demers C; Keshavjee K; Virani SA; Mancini GBJ; Wong ST ESC Heart Fail; 2023 Dec; 10(6):3612-3621. PubMed ID: 37786365 [TBL] [Abstract][Full Text] [Related]
16. Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives. van Haarst A; McGarvey L; Paglialunga S Clin Pharmacol Ther; 2019 Dec; 106(6):1222-1235. PubMed ID: 31334840 [TBL] [Abstract][Full Text] [Related]
17. Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. Krahnke JS; Abraham WT; Adamson PB; Bourge RC; Bauman J; Ginn G; Martinez FJ; Criner GJ; J Card Fail; 2015 Mar; 21(3):240-9. PubMed ID: 25541376 [TBL] [Abstract][Full Text] [Related]
18. Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice. Verberne LDM; Leemrijse CJ; Swinkels ICS; van Dijk CE; de Bakker DH; Nielen MMJ NPJ Prim Care Respir Med; 2017 Nov; 27(1):63. PubMed ID: 29167434 [TBL] [Abstract][Full Text] [Related]
19. Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008. Nishi SP; Wang Y; Kuo YF; Goodwin JS; Sharma G Ann Am Thorac Soc; 2013 Dec; 10(6):565-73. PubMed ID: 24053440 [TBL] [Abstract][Full Text] [Related]